Sens. Klobuchar, Wicker, Reps. Bilirakis, Matsui Announce New FDA Rare Disease Innovation Hub
July 27, 2024
July 27, 2024
WASHINGTON, July 27 -- Sen. Amy Klobuchar, D-Minnesota, issued the following news release:
U.S. Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) and U.S. Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA), co-chairs of the bipartisan Rare Disease Congressional Caucus (RDCC), applaud the Food and Drug Administration (FDA) announcement of the creation of a Rare Disease Innovation Hub.
The Rare Disease Innovation Hub will serve as a single point of connectio . . .
U.S. Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) and U.S. Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA), co-chairs of the bipartisan Rare Disease Congressional Caucus (RDCC), applaud the Food and Drug Administration (FDA) announcement of the creation of a Rare Disease Innovation Hub.
The Rare Disease Innovation Hub will serve as a single point of connectio . . .